Cannabis Rescheduling Is Coming: What It Means for Taxes, Registration, and Compliance

Michigan cannabis operators are facing a significant federal policy shift following the recent announcement to reschedule certain cannabis products, including state-licensed medical marijuana, from Schedule I to Schedule III. For many businesses, the news raises immediate questions around tax exposure, compliance requirements, operational planning, and what changes could impact profitability moving forward. If you are unsure how rescheduling could affect your organization, you are not alone. 

In this session, we’ll break down what the federal rescheduling announcement could mean for Michigan cannabis businesses, including the potential impact on medical versus adult-use markets, how Section 280E tax treatment may change, and what new DEA registration or compliance requirements could look like.  

Register today to gain practical insights, understand the potential risks and opportunities ahead, and walk away with a clearer picture of how to navigate the changing cannabis landscape with greater confidence. 

RSVP Here